Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines

Anderson, I. M.; Nutt, D. J.; Deakin, J. F. W.

doi:10.1177/026988110001400101

Cited by 310

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines

Anderson, I. M., Nutt, D. J., Deakin, J. F. W.·2000·Journal of Psychopharmacology

DOI 10.1177/026988110001400101

Open this paper in CoChat — free account

Abstract

A revision of the British Association for Psychopharmacology guidelines for treating depressive disorders with antidepressants was undertaken in order to specify the scope and target of the guidelines and to update the recommendations based explicitly on the available evidence. A consensus meeting, involving experts in depressive disorders and their treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from participants and interested parties. A literature review is given which identifies the quality of evidence followed by recommendations, the strength of which are based on the level of evidence. The guidelines cover the nature and detection of depressive disorders, acute treatment with antidepressant drugs, choice of drug versus alternative treatment, practical issues in prescribing, management when initial treatment fails, continuation treatment, maintenance treatment to prevent recurrence and stopping treatment.

Integrity signals

Registry

Crossref · 10.1177/026988110001400101

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Insomnia has been reported for phenelzine, tranylcypromine and isocarboxazid.
“Insomnia has been reported for phenelzine, tranylcypromine and isocarboxazid (Anderson et al., 2000), while significant REM sleep suppression has been noted with phenelzine and tranylcypromine (Winokur et al., 2001).”
From Antidepressants and their effect on sleep (2005) · cites this paper as Anderson et al., 2000
SSRIs are frequently associated with insomnia.
“SSRIs are frequently associated with insomnia (Anderson et al., 2000); around one-quarter of depressed patients in clinical trials report insomnia (Winokur et al., 2001).”
From Antidepressants and their effect on sleep (2005) · cites this paper as Anderson et al., 2000
SSRIs are commonly associated with insomnia.
“SSRIs are commonly associated with insomnia (Anderson et al., 2000), although occasionally daytime sleepiness has been reported with higher doses (Beasley Jr et al., 1992).”
From Antidepressants and their effect on sleep (2005) · cites this paper as Anderson et al., 2000

Conceptualization and Rationale for Consensus Definitions of Terms in Major Depressive Disorder: Remission, Recovery, Relapse, and Recurrence
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 2×
“Continuation, maintenance and stopping treatment A useful model of the course of major depression and its treatment proposes a continuum between depressive symptoms and major depression (Frank et al., 1991; Kupfer, 1991).”
Background
A Multifaceted Intervention to Improve Treatment of Depression in Primary Care
Katon, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830100072009 · Cited by 835
A meta-analysis of the effects of cognitive therapy in depressed patients
Gloaguen, V., Cottraux, J., Cucherat, M., & Blackburn, I.-M. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00199-7 · Cited by 809
Psychiatric disorder in a sample of the general population with and without chronic medical conditions
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.8.976 · Cited by 641
Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations
Thase, M. E. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230043006 · Cited by 515
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399 · cited 1×
“…patients with major depression (Ia) Systematic reviews and meta-analyses suggest that the commonly available antidepressants have comparable efficacy in the majority of patients seen in primary care or outpatient psychiatric settings (Song et al., 1993; Anderson, 1997, 1999; Geddes et al., 1999).”
Background
Changes in public attitudes to depression during the Defeat Depression Campaign
Paykel, E. S., Hart, D., & Priest, R. G. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.6.519 · Cited by 389 · cited 1×
“There is some evidence that strategies to increase the awareness and knowledge of both the public and doctors about depressive disorders and to train doctors in the detection and treatment of depressive disorders are effective (Grimshaw and Russell, 1993; Stevens et al., 1997; Paykel et al., 1998).”
Background
Lay people's attitudes to treatment of depression: results of opinion poll for Defeat Depression Campaign just before its launch
Priest, R. G., Vize, C., Roberts, A., Roberts, M., & Tylee, A. (1996) · BMJ · doi:10.1136/bmj.313.7061.858 · Cited by 385
Bibliotherapy in unipolar depression: A meta-analysis
Cuijpers, P. (1997) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/s0005-7916(97)00005-0 · Cited by 339
The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity
BEBBINGTON, P. E., DUNN, G., JENKINS, R., LEWIS, G., BRUGHA, T., FARRELL, M., & MELTZER, H. (1998) · Psychological Medicine · doi:10.1017/s0033291797006077 · Cited by 330
Relapse after recovery from unipolar depression: a critical review
Belsher, G., & Costello, C. G. (1988) · Psychological Bulletin · doi:10.1037/0033-2909.104.1.84 · Cited by 321
Effectiveness of antidepressants: Meta-analysis of dose-effect relationships in randomised clinical trials
Bollini, P., Pampaliona, S., Tibaldi, G., Kupelnick, B., & Munizza, C. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.4.297 · Cited by 274
Major depressive subtypes and treatment response
Fava, M., Uebelacker, L. A., Alpert, J. E., Nierenberg, A. A., Pava, J. A., & Rosenbaum, J. F. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00440-4 · Cited by 247
Life Events and Endogenous Depression: A Puzzle Reexamined
Brown, G. W. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070017006 · Cited by 230
Relapse of depression in primary care: Rate and clinical predictors
Lin, E. H. B. (1998) · Archives of Family Medicine · doi:10.1001/archfami.7.5.443 · Cited by 152 · cited 1×
“Similar figures are described in general practice patients (Lin et al., 1998) with 37% relapsing in 1 year.”
Classification in psychiatry: ICD–10 versus DSM–IV
Andrews, G., Slade, T., & Peters, L. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.174.1.3 · Cited by 145
Continuation and maintenance therapy with antidepressive agents: Meta-analysis of research
Loonen, A. J. M., Peer, P. G. M., & Zwanikken, G. J. (1991) · Pharmaceutisch Weekblad Scientific Edition · doi:10.1007/bf01957741 · Cited by 79

Flagged first, then by citations

Research works printed but not linked: 192

American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders
10.1192/apt.3.1.58 · DOI
10.1002/(SICI)1520-6394(1998)7:1+<11::AID-DA4>3.0.CO;2-I · DOI
Anderson I M, 1999, J Affect Dis
10.1136/bmj.315.7116.1143 · DOI
Angst J, 1993, Clin Neuropharmacol, 16, S55
10.1001/archpsyc.1996.01830090090013 · DOI
10.1192/bjp.159.4.510 · DOI
10.3109/13651509709069205 · DOI
10.1001/archpsyc.1988.01800360048007 · DOI
10.1136/bmj.303.6804.685 · DOI
10.1001/archpsyc.1976.01770120083009 · DOI
10.1016/0165-0327(88)90053-5 · DOI
10.1007/BF00172624 · DOI
10.1136/bmj.1.5741.133 · DOI
10.1016/0738-3991(94)90028-0 · DOI
British National Formulary, 1999, Number 37. British Medical Association and Royal Pharmaceutical Society of Great Britain
10.1016/0165-1781(92)90002-K · DOI
10.1111/j.1600-0447.1992.tb03218.x · DOI
10.1097/00004714-198704000-00004 · DOI
Burns, D, 1983, Feeling good
Chan C H, 1987, J Clin Psychiatry, 48, 197
Cole M G, 1999, Am J Psychiatry, 156, 1182, 10.1176/ajp.156.8.1182 · DOI
Conti L, 1989, New Trends Exp Clin Psychiatry, 5, 221
10.1176/ajp.149.1.100 · DOI
10.1001/archinte.1997.00440310079008 · DOI
10.1176/ps.49.2.196 · DOI · Paper page
Davidson J R T, 1999, J Clin Psychiatry, 60, 4
10.2165/00003495-199753040-00006 · DOI
Dawson R, 1998, J Affect Dis, 49, 31, 10.1016/S0165-0327(97)00181-X · DOI
10.1097/00004850-198801000-00005 · DOI
DeRubeis R J, 1999, Am J Psychiatry, 156, 1007, 10.1176/ajp.156.7.1007 · DOI
Depression Guideline Panel, 1993, Clinical practice guideline number 5. Depression in primary care, vol. 1. Detection and diagnosis
Depression Guideline Panel, 1993, Clinical practice guideline number 5. Depression in primary care, vol. 2. Treatment of major depression. US Department of Health and Human Services
10.1097/00004850-198701000-00001 · DOI
10.1111/j.1600-0447.1998.tb10114.x · DOI
10.1136/bmj.311.7015.1274 · DOI
10.1001/archpsyc.1991.01810280024003 · DOI
10.1177/026988119901300204 · DOI
10.1016/S0149-2918(00)88287-9 · DOI
10.1192/S0007125000293501 · DOI
10.1055/s-2007-1017076 · DOI
Entsuah R, 1999, A comparative pooled analysis of the effect of venlafaxine and selective serotonin reuptake inhibitors on remission in patients with major depression
10.1001/archpsyc.55.11.1026 · DOI
10.1007/s001270050093 · DOI
10.1176/ajp.143.7.888 · DOI
Fava G A, 1994, Am J Psychiatry, 151, 1296
10.1176/ajp.151.9.1372 · DOI
Feighner J P, 1994, J Clin Psychiatry, 55, 62
10.2165/00003495-199243040-00009 · DOI
10.1176/ajp.156.6.943 · DOI
Frances A J, 1998, J Clin Psychiatry, 59, 73
10.4088/JCP.v59n0504 · DOI
10.1001/archpsyc.1990.01810240013002 · DOI
10.1016/0165-0327(93)90001-Z · DOI
10.1136/bmj.290.6485.1880 · DOI
10.1016/S0140-6736(97)05298-7 · DOI
10.1016/S0165-0327(98)00129-3 · DOI
Geddes J R, 1999, The Cochrane Library
10.1016/0165-1781(89)90192-3 · DOI
Gill D, 1999, The Cochrane Library
10.1097/00005053-199102000-00001 · DOI
10.1097/00005053-198808000-00002 · DOI
10.1136/bmj.297.6653.897 · DOI · Paper page
10.1016/S0165-0327(98)00133-5 · DOI
Greden J F, 1993, J Clin Psychiatry, 54, 39
10.1016/0140-6736(93)92244-N · DOI
10.1001/archpsyc.56.6.519 · DOI
10.1177/026988119801200311 · DOI
10.1177/026988119901300321 · DOI
10.2165/00003088-199835010-00004 · DOI
Harvey I, 1998, Br J Gen Pract, 48, 1043
10.1136/bmj.310.6974.221 · DOI
10.1136/bmj.298.6668.223 · DOI
10.1192/bjp.170.2.120 · DOI
10.1111/j.1600-0447.1992.tb03209.x · DOI
10.1016/S0165-0327(98)00083-4 · DOI
10.1176/ajp.151.4.530 · DOI
10.1017/S0033291797005308 · DOI
10.1001/archpsyc.1997.01830230015002 · DOI · Paper page
10.1001/archpsyc.55.8.694 · DOI · Paper page
10.1001/jama.1995.03520370068039 · DOI · Paper page
10.1017/S0033291700024831 · DOI
10.1111/j.1600-0447.1994.tb05880.x · DOI
10.1001/archpsyc.1992.01820100053010 · DOI · Paper page
10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
10.1016/0165-0327(89)90021-9 · DOI
10.1176/ajp.147.5.621 · DOI
10.1097/00004714-199512000-00006 · DOI
Kupfer D J, 1991, J Clin Psychiatry, 52, 28
Lancaster S G, 1989, Drugs, 37, 123, 10.2165/00003495-198937020-00003 · DOI
Lejoyeux M, 1997, J Clin Psychiatry, 58, 11
Lima M S, 1999, The Cochrane Library
Lin E H, 1999, Am J Psychiatry, 156, 643, 10.1176/ajp.156.4.643 · DOI
10.1097/00005650-199708000-00008 · DOI
Linde K, 1999, The Cochrane Library
10.1080/0097840X.1981.9934538 · DOI
10.1136/bmj.313.7048.26 · DOI
10.1016/0165-0327(94)90015-9 · DOI
10.1136/bmj.318.7192.1180 · DOI
10.1176/ajp.151.8.1114 · DOI
10.1136/bmj.314.7081.646 · DOI
Mason J, 1999, Health Trends, 30, 120
10.1176/ajp.150.1.118 · DOI
10.1016/S0165-0327(97)00107-9 · DOI
10.1192/S0007125000293264 · DOI
10.1177/0269881193007001041 · DOI
10.1097/00004850-199300830-00008 · DOI
10.1097/00004850-199400910-00008 · DOI
10.1159/000058878 · DOI
10.1016/S0140-6736(96)07495-8 · DOI · Paper page
10.1017/S0033291796004126 · DOI
10.1136/bmj.310.6977.441 · DOI
10.1016/0165-0327(90)90032-4 · DOI
Nobler M S, 1994, Refractory depression: current strategies and future directions, 69
Nolen W A, 1988, Acta Psychiatr Scand, 78, 668, 10.1111/j.1600-0447.1988.tb06402.x · DOI
Nolen W A, 1988, Acta Psychiatr Scand, 78, 676, 10.1111/j.1600-0447.1988.tb06403.x · DOI
10.1192/bjp.162.2.175 · DOI
10.1176/ajp.150.4.571 · DOI
Ottevanger E A, 1991, Br J Clin Res, 2, 125
10.2165/00023210-199504040-00001 · DOI
10.1016/0006-3223(95)00628-1 · DOI
10.1016/S0165-0327(96)00073-0 · DOI
10.1017/S003329170001429X · DOI
10.1016/0165-0327(88)90075-4 · DOI
10.1192/bjp.164.4.549 · DOI
10.1001/archpsyc.1996.01830040013003 · DOI
10.1136/bmj.319.7210.612 · DOI
Pharmacia & Upjohn Limited, 1997, Edronax (reboxetine): summary of product characteristics
10.1192/bjp.166.4.424 · DOI
10.1176/ajp.143.1.18 · DOI
10.1001/archpsyc.1984.01790140028003 · DOI
10.1001/archpsyc.1987.01800150071009 · DOI
10.1001/archpsyc.1991.01810280035005 · DOI
Quitkin F M, 1991, Am J Psychiatry, 148, 193, 10.1176/ajp.148.2.193 · DOI
10.1176/ajp.150.4.566 · DOI
Quitkin F M, 1996, When should clinicians switch antidepressants? Arch Gen Psychiatry, 53, 785
10.1192/bjp.174.2.128 · DOI
10.1176/ajp.155.9.1247 · DOI · Paper page
Revicki D A, 1998, J Fam Pract, 47, 446
Reynolds C F, 1999, Am J Psychiatry, 156, 1177, 10.1176/ajp.156.8.1177 · DOI
Robinson P, 1997, J Fam Pract, 44, 562
10.3109/00048679709062683 · DOI
10.1192/bjp.171.5.427 · DOI
10.1016/S0006-3223(98)00126-7 · DOI · Paper page
10.1007/s002280050275 · DOI
10.1016/S0163-8343(97)00095-9 · DOI
10.1176/ajp.151.4.489 · DOI
10.1111/j.1600-0447.1992.tb01448.x · DOI
10.1111/j.1600-0447.1996.tb10673.x · DOI
10.1111/j.1600-0447.1993.tb03470.x · DOI
10.1001/archpsyc.1996.01830100061008 · DOI
10.1001/archpsyc.55.12.1121 · DOI
Schulberg H C, 1999, J Clin Psychiatry, 60, 19
10.1016/S0163-8343(96)00062-X · DOI
10.1192/bjp.171.2.131 · DOI
10.1192/bjp.167.3.289 · DOI
10.1176/ajp.147.6.711 · DOI
10.1136/bmj.318.7183.593 · DOI
10.1016/S0163-8343(98)00072-3 · DOI
10.1001/archfami.8.4.319 · DOI
10.1007/BF02602759 · DOI
10.2165/00023210-199500041-00007 · DOI
10.1016/S0165-0327(99)00014-2 · DOI
10.1176/ajp.148.8.997 · DOI · Paper page
10.1192/bjp.158.5.666 · DOI
10.1046/j.1365-2923.1997.00670.x · DOI
10.1001/archpsyc.55.4.334 · DOI · Paper page
10.1097/00004850-199100630-00007 · DOI
10.1192/bjp.169.3.338 · DOI
10.1097/00004850-199501004-00003 · DOI
Tamura, R, Annual Meeting of American Psychiatric Association 1998
10.1176/ajp.142.2.155 · DOI
Taylor, D, 1999, The Bethlam & Maudsley NHS Trust prescribing guidelines
10.1002/(SICI)1520-6394(1997)5:4<190::AID-DA5>3.0.CO;2-H · DOI · Paper page
10.2165/00023210-199504040-00004 · DOI
10.1016/S0165-0327(99)00033-6 · DOI
10.1176/ajp.149.2.195 · DOI · Paper page
10.1016/0893-133X(94)00058-8 · DOI
10.4088/JCP.v58n0103 · DOI
10.1176/ajp.153.5.636 · DOI
10.1016/S0163-8343(98)00077-2 · DOI
10.1111/j.1600-0447.1996.tb09872.x · DOI
Trivedi, M H, Annual Meeting of American Psychiatric Association 1998
Tylee A, 1995, Br J Gen Pract, 45, 575
10.1016/0165-0327(91)90036-R · DOI
10.1001/archpsyc.1994.03950080011002 · DOI
10.1001/jama.1996.03540040037030 · DOI · Paper page
10.1046/j.1525-1497.1997.00076.x · DOI · Paper page
Wilkinson M J, 1988, J Royal Coll Gen Pract, 38, 311
World Health Organization, 1992, The ICD-10 classification of mental and behavioural disorders-clinical descriptions and diagnostic guidelines
10.1111/j.1600-0447.1983.tb09716.x · DOI · Paper page

Sorted by citations

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945
Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies
Ruhé, H. G., Mason, N. S., & Schene, A. H. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001949 · Cited by 861
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., Ninan, P. T., Thase, M. E., Gelenberg, A. J., Kupfer, D. J., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301131 · Cited by 707
Antidepressants and their effect on sleep
Mayers, A. G., & Baldwin, D. S. (2005) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.726 · Cited by 323
Escitalopram versus other antidepressive agents for depression
Cipriani, A., Santilli, C., Furukawa, T. A., Signoretti, A., Nakagawa, A., McGuire, H., Churchill, R., & Barbui, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006532.pub2 · Cited by 190
Depressive disorders: treatment failures and poor prognosis over the last 50 years
Blackburn, T. P. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.472 · Cited by 136
Prescribing and deprescribing guidance for benzodiazepine and benzodiazepine receptor agonist use in adults with depression, anxiety, and insomnia: an international scoping review
Brandt, J., Bressi, J., Lê, M.-L., Neal, D., Cadogan, C., Witt-Doerring, J., Witt-Doerring, M., & Wright, S. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102507 · Cited by 77

Authors: Anderson, I. M., Nutt, D. J., & Deakin, J. F. W.
Affiliations: University of Manchester Department of Psychiatry, University of Manchester, Oxford Road, Manchester,
University of Bristol, Psychopharmacology Unit, School of Medical Sciences, Bristol, UK
University of Manchester Department of Psychiatry, University of Manchester, Oxford Road, Manchester
Venue: Journal of Psychopharmacology
Publisher: SAGE Publications
Published: 2000-01
Volume: 14
Issue: 1
Pages: 3-20
ISSN: 0269-8811
1461-7285
DOI: 10.1177/026988110001400101
Cited by: 310
References: 17
Language: en
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Metadata

Record

About these checks